You have access
Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
CHIYOE KITAGAWA, MASAHIRO IWASAKU, YOSHIHITO KOGURE, MASAHIKO ANDO, HIROSHIGE YOSHIOKA, AKIHIRO NISHIYAMA, NAOKI WATANABE, KEI KUNIMASA, KAZUYA TSUBOUCHI, SAORI OKA and HIDEO SAKA
In Vivo January 2019, 33 (1) 163-166; DOI: https://doi.org/10.21873/invivo.11453